131 related articles for article (PubMed ID: 24519575)
21. Two new convenient syntheses of 14C-squalene from turbinaric acid.
Philippe N; Rivron L; De Bruin B; Schofield J; Roy S
J Labelled Comp Radiopharm; 2018 Oct; 61(12):878-884. PubMed ID: 30066967
[TBL] [Abstract][Full Text] [Related]
22. Kinetic and mechanistic insight into the thermodynamic degradation of saxagliptin.
Jones GS; Savage SA; Ivy S; Benitez PL; Ramirez A
J Org Chem; 2011 Dec; 76(24):10332-7. PubMed ID: 22054301
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of enantiomerically pure [
Edelmann MR; Hartung T; Trussardi R; Iding H; Galley G; Pflieger P; Norcross RD
J Labelled Comp Radiopharm; 2016 Dec; 59(14):635-639. PubMed ID: 27196363
[TBL] [Abstract][Full Text] [Related]
24. A convergent stereocontrolled synthesis of [3-(14) C]solanesol.
Roe SJ; Oldfield MF; Geach N; Baxter A
J Labelled Comp Radiopharm; 2013; 56(9-10):485-91. PubMed ID: 24285526
[TBL] [Abstract][Full Text] [Related]
25. A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium.
Latli B; Hrapchak M; Gao JJ; Busacca CA; Senanayake CH
J Labelled Comp Radiopharm; 2015 Jul; 58(9):390-4. PubMed ID: 26190342
[TBL] [Abstract][Full Text] [Related]
26. Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Augeri DJ; Robl JA; Betebenner DA; Magnin DR; Khanna A; Robertson JG; Wang A; Simpkins LM; Taunk P; Huang Q; Han SP; Abboa-Offei B; Cap M; Xin L; Tao L; Tozzo E; Welzel GE; Egan DM; Marcinkeviciene J; Chang SY; Biller SA; Kirby MS; Parker RA; Hamann LG
J Med Chem; 2005 Jul; 48(15):5025-37. PubMed ID: 16033281
[TBL] [Abstract][Full Text] [Related]
27. Application of HPLC mixed-mode chromatography in determining radiochemical purity of [(14) C] labeled metformin hydrochloride.
Truong V; Helmy R; Ren S; Schenk D; Waterhouse D
J Labelled Comp Radiopharm; 2015 Apr; 58(4):177-9. PubMed ID: 25720824
[TBL] [Abstract][Full Text] [Related]
28. Syntheses of a radiolabelled CXCR2 antagonist AZD5069 and its major human metabolite.
Hickey MJ; Allen PH; Caffrey M; Hansen P; Kingston LP; Wilkinson DJ
J Labelled Comp Radiopharm; 2016 Sep; 59(11):432-8. PubMed ID: 27461061
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections.
Fura A; Khanna A; Vyas V; Koplowitz B; Chang SY; Caporuscio C; Boulton DW; Christopher LJ; Chadwick KD; Hamann LG; Humphreys WG; Kirby M
Drug Metab Dispos; 2009 Jun; 37(6):1164-71. PubMed ID: 19251818
[TBL] [Abstract][Full Text] [Related]
30. A potent IκB kinase-β inhibitor labeled with carbon-14 and deuterium.
Latli B; Eriksson M; Hrapchak M; Busacca CA; Senanayake CH
J Labelled Comp Radiopharm; 2016 Jun; 59(8):300-4. PubMed ID: 27073120
[TBL] [Abstract][Full Text] [Related]
31. A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes.
Frederich R; Alexander JH; Fiedorek FT; Donovan M; Berglind N; Harris S; Chen R; Wolf R; Mahaffey KW
Postgrad Med; 2010 May; 122(3):16-27. PubMed ID: 20463410
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of two potent glucocorticoid receptor agonists labeled with carbon-14 and stable isotopes.
Latli B; Reeves JT; Tan Z; Hrapchak M; Song JJ; Busacca CB; Senanayake CH
J Labelled Comp Radiopharm; 2015; 58(11-12):445-52. PubMed ID: 26391408
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of dipeptidylpeptidase-4 inhibitors.
Scheen AJ
Diabetes Obes Metab; 2010 Aug; 12(8):648-58. PubMed ID: 20590741
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of carbon-14 and stable isotope labeled Censavudine.
Burrell RC; Bonacorsi SJ; Ortiz A; Benkovics T; Shi Z
J Labelled Comp Radiopharm; 2022 Apr; 65(4):112-122. PubMed ID: 35106813
[TBL] [Abstract][Full Text] [Related]
35. Exploration of the DPP-4 inhibitors with a focus on saxagliptin.
Shubrook JH; Colucci RA; Schwartz FL
Expert Opin Pharmacother; 2009 Dec; 10(17):2927-34. PubMed ID: 19929711
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of [13C]- and [14C]-labeled phenolic humus and lignin monomers.
Ji R; Chen Z; Corvini PF; Kappler A; Brune A; Haider K; Schäffer A
Chemosphere; 2005 Sep; 60(9):1169-81. PubMed ID: 16018886
[TBL] [Abstract][Full Text] [Related]
37. [High-yield synthesis of 14C labeled alicyclic amino acids with high specific radioactivity using potassium (14C) cyanide].
Shiba K; Mori H; Hisada K
Radioisotopes; 1986 Jul; 35(7):361-6. PubMed ID: 3786840
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of 2 C-14 labeled cathepsin C inhibitors: The use of a cyanide to displace a Benzotriazole.
Kingston L; Bergare J; Lönn H; Ericsson C; Grönberg G; Chen S; Elmore CS
J Labelled Comp Radiopharm; 2017 May; 60(6):294-301. PubMed ID: 28324911
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of three alpha 7 agonists in labeled form.
Elmore CS; Landvatter S; Dorff PN; Powell ME; Killick D; Blake T; Hall J; Heys JR; Harding J; Urbanek R; Ernst G
J Labelled Comp Radiopharm; 2014 May; 57(5):342-9. PubMed ID: 24700683
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of carbon-11 labelled glycine and the dipeptides L-phenylalanylglycine and L-leucylglycine.
Bolster JM; Vaalburg W; Elsinga PH; Woldring MG; Wynberg H
Int J Rad Appl Instrum A; 1986; 37(9):985-7. PubMed ID: 3021684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
